摘要
目的:观察超微黑地黄汤:①对慢性肾脏病(CKD)3期患者的临床疗效;②对单侧输尿管结扎大鼠行为、体态、体重及其肾脏组织病理的影响;③对单侧输尿管结扎大鼠肾组织细胞凋亡的影响;④对单侧输尿管结扎大鼠FN、ColⅣ、TGF-β1的调节作用。
方法:临床研究—随机将60例CKD3期患者分为超微组和尿毒清组,比较两组患者治疗前后血红蛋白、血肌酐、尿素氮、24小时尿蛋白定量的变化。动物实验—将40只单侧输尿管结扎(UU0)SD大鼠按照完全随机的方法分为空白组、假手术组、模型组、超微组和尿毒清组,干预14天后,观察下列指标:①单侧输尿管结扎大鼠行为、体态、体重及其肾脏组织病理学;②采用免疫组织化学方法检测各组大鼠肾组织Bcl-2、Bax,并与细胞凋亡原位检测(TUNEL法)进行对比;③各组大鼠血肌酐、尿素氮、24小时尿蛋白定量;④采用酶联免疫吸附法(ELISA)及其免疫组织化学方法检测各组大鼠血清FN、ColⅣ、TGF-β1的浓度值。
结果:超微组和尿毒清组总有效率相近(P>0.05)。对血肌酐、尿素氮和24小时尿蛋白定量均有改善作用(P<0.05),但对血红蛋白无明显改善作用(P>0.05),而两组血肌酐的改善无统计学差异(P>0.05),尿素氮的改善尿毒清组优于超微组(P<0.05),而24小时尿蛋白定量的改善情况是超微组优于尿毒清组(P<0.05)。干预后模型组行为、体态及体重的改变均明显异于其他组大鼠,而病理改变最严重。超微组大鼠肾功能和尿蛋白定量均明显优于模型组(P<0.05),与尿毒清具有相近疗效(P>0.05);超微组和尿毒清组大鼠血清中所含的FN、ColⅣ浓度相近(P>0.05),而低于模型组大鼠(P<0.05);超微组和尿毒清组大鼠Bcl-2均高于模型组(P<0.05),而Bax、TGFβ1均低于模型组(P<0.05)。TUNEL法检测的细胞凋亡显示超微组与尿毒清组的细胞凋亡数少于模型组(P<0.05)。
结论:本研究结果证明:①超微黑地黄汤治疗脾肾气虚型CKD3期患者,安全有效,且疗效与尿毒清相似;②超微黑地黄汤对UUO大鼠的行为、体态、体重及肾脏组织病理有明确改善作用;③超微黑地黄汤有降低UUO大鼠24小时尿蛋白定量,改善肾功能的作用;④超微黑地黄汤的临床疗效与其能够减少肾组织中肾小管上皮细胞的凋亡,抑制FN、ColIV、TGF-β1的表达有关。
Objective:To investigate①the clinical effect of super-micro Black Dihuang decoction on Chronic Kidney Disease (CKD) 3 degree.②the influence of super-micro Black Dihuang decoction on behavior, posture, weight and pathological kidney of UUO rats.③the effect of super-micro Black Dihuang decoction on apoptosis and renal organization Bcl-2、Bax of Unilateral Ureteral Obstruction (UUO) rats.④the effect of super-micro Black Dihuang decoction on serum FN、ColⅣ、TGFβ1 of Unilateral Ureteral Obstruction (UUO) rats.
Methods:Clinical study:60 CKD 3 degree patients were divided randomly into the Super-micro group and Niaoduqing group,compared the 24-hour urinary protein quantitative,serum creatinine, urea nitrogen and the efficacy before and after treatment. Animal experiment:40 Unilateral Ureteral Obstruction (UUO) SD rats were randomized into Control group, Sham operation group, Model group, Super-micro group and Niaoduqing group. After 14 days, next indicators of each group rats were detected:①behavior, posture, weight and pathological kidney of UUO rats.②the concentration of Bcl-2 and Bax with immunohistochemistry method, and compared with the apoptosis of renal organization with TUNEL method③the rat kidney morphology of each group.④the serum creatinine, urea nitrogen and 24-hour urine protein of each group.⑤the concentration of FN、ColⅣin serum with enzyme-linked timmunosorbent assay (ELISA) method, and the concentration of TGFβ1 with immunohistochemistry method.
Results:The total effective of Super-micro group and the Niaoduqing group is similar (P>0.05). Both two groups were improved On serum creatinine, urea nitrogen and 24-hour urine protein quantitative (P<0.05), but no difference on hemoglobin and no significant difference between Super-micro group and the Niaoduqing group in the improvement of serum creatinine (P>0.05), urea nitrogen to improve in Niaoduqing group is better than that of Super-micro group (P<0.05), while the 24-hour urinary protein of Super-micro group to improve was better than Niaoduqing group (P<0.05). The behavior, posture and weight changes of model group were significantly different from the other group, In pathology, Super-micro group was simila with Niaoduqing group, but significantly different from the model group. Super-micro Black Dihuang decoction on renal function and urinary protein were clearly improved effect (P<0.05). Experimental study also was found a similar effect (P> 0.05) between Super-micro rats group and Niaoduqing rats group, while serum FN、ColⅣconcentrations of Super-micro Black Dihuang decoction were found similar levels as those of Niaoduqing (P> 0.05), but much lower than that of the model group (P<0.05). Bcl-2 of Super-micro group and Niaoduqing group were higher than model group (P<0.05), while Bax and TGFβ1 of Super-micro group and Niaoduqing group were lower than the model group (P<0.05). The apoptosis of Super-micro group and Niaoduqing group are lower than that of the model group (P <0.05).
Conclusion:①Super-micro Black Dihuang decoction group with Spleen and Kidney deficiency type can be treated safely and effectively, whose effect is similar with that of Niaoduqing.②The behavior, body weight and renal pathology of Super-micro Black Dihuang decoction group has a clear role.③Super-micro Black Dihuang decoction can reduce the 24-hour urine protein, improve kidney function.④Supermicro Black Dihuang decoction can inhibit FN, ColⅣ, TGFβ1, which can reduce the apoptosis of renal.
引文
1.Zhou BT, Conny A. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis,1998,19:1-27.
2.薛痕,陈亮,樊均明,等.MMP-9与TIMP-1在肾小管上皮细胞转分化中的作用.四川大学学报(医学版),2008,39(1):34-38.
3.杨继红,郑法雷,吴华,等.胰岛素样生长因子—Ⅰ对体外培养的肾小管上皮细胞表型转化的作用[J].基础医学与临床,2005;25(5):459.
4.Yang YX, Han SP, Han YX, et al. Effects of I)a Huang HuoLing Tang on the expression of PIX; F1、Bfgf in Rats with Re. hal failure Caused by Adeninel. Journal of Sichuan of Traditional Chinese Medicine,2007,25(2):26-28.
5.俞娅芬,董吉祥.TGF-β在慢性肾脏疾病中的作用[J].国外医学泌尿系统分册,2005,25(1):132-134.
6.高燕,陈航,袁爱军,等.实验性肾间质纤维化大鼠肾小管上皮细胞凋亡的观察[J].医学研究与教育,2009;26(4):11-13.
7. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Am J Kidney Dis.2002; 39(2 Suppl 1):S1-$266.
8.郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社.2002:163-168.
9.陆晨,杨淑芬,岳华.慢性肾脏病的流行病学调查现状.医学综述,2008,14(3):370-371
10.谷丽丽,张雪梅,田莉瑛,等.中药超微粉碎技术的应用及进展.生命科学仪器,2008;6(8):49-52.
11.孙强,何应.当归超微粉的药剂学研究[J].中国药房,2007,18(15):1141-1143.
12.蔡光先,赵迪加,张水寒,等.中药微粉粒度的评价初探[J].中成药,2007.29(5):719-722.
13.刘永,付廷明,郭立玮,等.紫河车超细粉体的表征技术研究[J].中华中医药学刊,2007,25(4):833-834.
14.黎华明.中药超微饮片与汤剂治疗老年性皮肤瘙痒症75例疗效对比观察.中医药导报,2005;11(10):31-33.
15.屈波,蔡光先,刘柏炎,等.超微六味地黄汤对孕期被动吸烟胎鼠脑Bax、Bcl-2和Casepase-3的影响.实用预防医学,2008;15(6):1679-1682.
16.王小沛.黑地黄丸临床运用举隅.河南中医,2008,28(3):63-64
17.张法荣,王芳,付海霞,等.黑地黄丸治疗慢性肾衰竭的临床观察.中国中西医结合肾病杂志.2009,10(2):156-157
18.张凡珍,高伟,王芳,等.黑地黄丸治疗肾性贫血的临床观察.甘肃中医学院学报.2009,26(3):15-17
19.黄仁发,史伟,吴金玉,等.怡肾汤治疗慢性肾衰竭的疗效观察及对免疫功能的影响.湖南中医药大学学报,2007;27(6):52-54.
20.陈北阳,龙若庭,何泽云,等.怡肾汤对大鼠5/6肾切除术后残肾肾功能及组织形态学的影响.湖南中医学院学报,2005;25(3):11-13.
21.龙若庭,何泽云.怡肾汤对5/6肾切除大鼠残肾组织形态与Col—Ⅳ及MMP—2的干预作用.中国中西医结合肾病杂志,2006;7(6):324-327.
22.安会江,朝克,商战平,等.实验性单侧输尿管梗阻色肾脏形态学变化[J].基础医学与临床,1999,19(3):61-64.
23.朱明德,张介玉,沈惠凤.血源性感染肾间质纤维化动物模型制作[J].上海第二医科大学学报,1992,.12(4):356-357.
24. ShimizuT,KurodaS,HataS,et al.Pirfendone improves renal function and fi brosis in postobstruction kidney [J]. Kidney Int,1998,54(1):99-109.
25.黄红,张国强,叶任高,等.胞增殖与凋亡在单侧输尿管梗阻大鼠肾间质纤维化发病中的意义[J].中华华肾脏病杂志,2000,16(1):24-27.
26.陈献花,叶小弟,王军,等.三种大鼠肾小管间质损伤模型的比较实验研究[J].中国比较医学杂志,2003,13(2):90-92.
27. klahr S, MorrisseyJ. Obstructive ephropathy and renal fibrosis [J]. Am J Physiol 2002,283(5):861-875.
28.Letai,A. (2005) Pharmacological manipulation of Bcl-2 family members to control cell death. J. Clin. Invest.,115,2648-2655.
29.Dejean,L.M., Martinez-Caballero,S., Manon,S. and Kinnally,K.W. (2006) Regulation of the mitochondrial apoptosis-induced channel, MAC, by Bcl-2 family proteins. Biochimica. et. Biophysica. Acta.1762,191-201.
30. Gobe G, Zhang X J, Wiugoss DA, et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat[J]. J Am Soc Nephrol,2000,11(3):454-467
31.黄凌虹,张国强,叶任高,等.细胞增殖与凋亡在单侧输尿管梗阻大鼠肾间质纤维化发病中的意义[J].中华肾脏病杂志,2000,16(1):24--27.
32.车鸣,刘保江.不同剂量瑞芬太尼对缺血再灌注时大鼠肾细胞凋亡和bcl-2、bax表达的影响.中外医疗.2010,(13):128,130
33.苏震,郑法雷,李艳,等.转化生长因子-β和表皮生长因子在诱导人肾小管上皮细胞转分化中的作用[J].中华检验医学杂志,2002;25(5):268-70
34.杨继红,郑法雷,吴华,等.胰岛素样生长因子-I对体外培养的肾小管上皮细胞表型转化的作用[J].基础医学与临床,2005;25(5):459.
35.刘颖,张翠,王晓泊.内皮素与肾间质纤维化的关系及中药干预[J].上海医药,2007;28(6):271-273.
36.陈继贵,邰智慧,刘坤,等.肾间质纤维化中结缔组织生长因子(CTGF)与肾小管上皮细胞表型转化的关系.中国实验诊断学,2010;14(1):69-71.
37.Yang YX, Han SP, Han YX, et al. Effects of I)a Huang HuoLing Tang on the expression of PIX;-F1、Bfgf in Rats with Re. hal failure Caused by Adeninel. Journal of Sichuan of Tradition-al Chinese Medicine,2007,25(2):26-28.
38.浦江美由纪.IgA肾病肾小球内Fibronectin的分布式样[J].日肾志(日文),1990。32:389.
39. Ortega VR, Gonzalez RM, Ruiz-Torres MP, et al. Collagen I upregulates extra cellular matrix gene expression and secretion Of TGF-beta 1 by cultured human mesangial cells. Am J Physiol Cell Physiol,2004,286(6):C1335-C1343.
404.Io H, Hamada C,Fukui M, et al. Relationship between levels of urinarytype IV collagen and renal injuries in patients with IgA nephropathy. J Clin Lab Anal, 2004,18(1):14-18.
415.郑京,刘新迎,丘余良,等,慢性肾脏病患者血及尿Col—Ⅳ与LN的检测.中国中西医结合肾病杂志,2004,5(9):533-534.
426.席春生,刘丽,邓芝云等.血Ⅳ-c在肾小球疾病中的变化及临床意义.中国现代医学杂志,2000,10(4):66.
43.贾明,邹红云,贾保林.136例Ⅳ型胶原检测结果分析.中国现代医学杂志,2003,13(21):107--108.
44.林英辉.不同类型工gA肾病患者血清Ⅳ型胶原含量与其病理变化的相关性分析.中国医师杂志,2007,9(12):1701-1702.
45.余亚敏,何泽云,陈北阳,等.六味地黄汤对大鼠单侧输尿管结扎后肾小管间质ColⅣ及TIMP-1表达的影响.湖南中医学院学报,2006,26(4):22-24
46.李雄,柳飞,付平,等.TGF-β/CTGF在肾脏纤维化机制中的作用及中药治疗影响[J].中国中西医结合肾病杂志,2006,7(6):370-372.
47.Pavan MV, Ghini B, Castro M, et al. Prevention of hypertension attenuates albttminuria and renal expression of fibroneetin in diabetic spontaneously hypertensive rats[J]. Am J Nephrol,2003,23(6):422-428.
48.Yokoi H, Mukoyana M, sugawara A, et al. Role of connective tissue growth factor in fibronection expression and tubulointerstitial fibrosis [J]. Am J Physiol, 2002,282(5):933-942.
49.刘小平,胡顺金,方琦。大鼠IgA肾病模型的建立及血清中IL一6、FN、NO的检测。中困比较医学杂志;2008(18),1:5-8
50.程悦,王代红,张耀全,等.PTEN编码蛋白对TGF-β1刺激大鼠肾成纤维细胞分泌CollⅤ、FN的抑制作用.解放军医学杂志,2007,32(7):719-721
51.孟立强,屈磊,李晓玫.黄芪当归合剂对肾间质纤维化的多靶点抑制作用[J].中国药理学通报,2006,22(3):296.
52. Shihab FS, Bennett WM, Yi H, et al. Pidenidone treatment decreases transform ing growth factor-bl and matrix proteins an d ameliorates fibrosis in chronic eyelosporine nephrotoxity[J]. Am J Transplant,2002,2:111-119.
53.Yang B, Johnson TS, Th omas GL, et al. Expression of apoptosisrelated genes in experiment chronic renal carring[J]. J Am SocNephrol,2001,12:275-288.
54.Truong LD, Chol YJ, Tsao CC, et al. Renal cel apeptosis in chronic obstructive uropathy:the roles of caspases[J]. Kidney lnt,2001,60:924-934.
55.许庆友,潘莉,王月华,等.红花对肾间质纤维化实验大鼠肾小管上皮细胞表型转化的抑制作用[J].中国老年学杂志,2009;29(11):1344-1346.
56.黄娟陈文莉朱虹.大黄酸对输尿管梗阻大鼠肾组织纤维化的保护机制[J1.中国药师,2009;12(11):1529-1531.
57.林琼真,于洁,邓英辉,等.丹参注射液对大鼠梗阻性肾间质纤维化的保护作用[J].中国中西医结合肾病杂志,2003;4(2):71-73.
58.谢席胜,冯胜刚,左川,等.三七总皂甙对单侧输尿管梗阻后大鼠肾间质纤维化的作用及机制研究[J].西部医学,2010;22(2):210-214.
59.左川,谢席胜,邱红渝,等.黄芪对U U O大鼠肾间质纤维化拮抗作用[J].现代预防医学,2008;35(12):2298-2300.
60.谢红东,杨珂,穆焕德,等.黄芩提取物对大鼠肾间质纤维化的作用及其抗氧化机制[J].中国中西医结合肾病杂志,2009;10(3):240-242.
61.程虹,宋恩峰,杜仲对UUO模型大鼠肾纤维化TGF-β1/Smad信号通路的影响[J].中国中西医结合肾病杂志,2009;10(6):502-504.
62.项琼,宋恩峰,贾汝汉,等,泽兰对单侧输尿管梗阻大鼠肾间质纤维化的影响[J].中国中西医结合肾病杂志,2009;10(3):197-200.
63.李相军,王丹,石艳,等,银杏叶提取物对体外培养大鼠肾成纤维细胞作用的实验研究[J].中国实验诊断学,2010;14(1):45-47.
64.程晓霞,王军,周大为.人工虫草提取物对大鼠单侧输尿管梗阻致肾小管间质损伤的保护作用[J].中国中西医结合肾病杂志,2004,5(8):440-442.
65.李小波,李均,师丽晶.桃仁对单侧输尿管梗阻大鼠肾组织NF-κB, TNF-β1表达的影响.中国中医基础医学杂志,2006,12(7):526--527.
66.李均,李小波.温阳活血方对UUO大鼠肾组织TGF-β1表达的影响.中国中西医结合肾病杂志,2007,8(3):142-144.
67张聪,谌贻璞,杨彦芳,等.益肾软坚散对慢性马兜铃酸肾病大鼠模型肾间质纤维化的保护作用[J].中国中西医结合杂志,2005;25(8):714-718.
68.董华玲,马华,中药芪红合剂对肾间质纤维化模型大鼠肾组织中CTGF表达的影响[J].中外医药,2009;(4):10-12.
69.杨琳,刘丽,景朋,等.益气活血中药对肾间质纤维化大鼠肾组织中Ⅰ、Ⅲ型胶原,MMP-1和TIMP-1表达的影响[J].北京中医药,2009;28(10):816-818.
70.陆敏,周娟,王飞,等,血府逐瘀胶囊对单侧输尿管梗阻大鼠SnoN和Ski表达的影响[J].上海中医药大学学报,2008;22(6):35-38.
71.余亚敏,何泽云,陈北阳,等,六味地黄汤对大鼠单侧输尿管结扎后肾小管间质ColⅣ及TIMP-1表达的影响[J].湖南中医学院学报,2006,26(4)22-24.
72.彭亚军,张继波,何泽云,等,六味地黄汤对单侧输尿管结扎大鼠肾间质MCP—1及TGF-β1表达的影响[J].中国中西医结合肾病杂志,2009;10(7):587-590.
73.刘海军,于俊生,和络泄浊方防治单侧输尿管梗阻后大鼠肾间质纤维化的研究[J].山东中医杂志,2008;27(11):768-771.
74.晏子友,皮持衡,陈法根.肾间质纤维化的研究进展[J].现代诊断与治疗,2000,11(5):279-282.
75.赵雅妮,李惊子,王海燕.血管紧张素Ⅱ受体拮抗剂与血管紧张素转换酶抑制剂抗大鼠肾脏纤维化的作用及机制探讨[J].中华老年多器官疾病杂志。2002,1(1):3640.
76.王刚,邓安国,张春,等.1,25(OH)2D3阻抑UUO大鼠肾间质纤维化的实验研究[J]. J Nephrol Dialy Transplant.2002; 11(1):46-48. Bcl-2Casepase-3BaxCasepase-3
1.苏震,郑法雷,李艳,等.转化生长因子-β和表皮生长因子在诱导人肾小管上皮细胞转分化中的作用[J].中华检验医学杂志,2002;25(5):268-70
2.杨继红,郑法雷,吴华,等.胰岛素样生长因子-I对体外培养的肾小管上皮细胞表型转化的作用[J].基础医学与临床,2005;25(5):459.
3.刘颖,张翠,王晓泊.内皮素与肾间质纤维化的关系及中药干预[J].上海医药,2007;28(6):271-273.
4.陈继贵,邰智慧,刘坤,等.肾间质纤维化中结缔组织生长因子(CTGF)与肾小管上皮细胞表型转化的关系.中国实验诊断学,2010;14(1):69-71.
5.薛痕,陈亮,樊均明,等.MMP-9与TIMP-1在肾小管上皮细胞转分化中的作用.四川大学学报(医学版),2008,39(1):34-38.
6. Yang YX, Han SP, Han YX, et al. Effects of Da Huang HuoLing Tang on the expression of PDGF1、Bfgf in Rats with Renal failure Caused by Adeninel. Journal of Sichuan of Traditional Chinese Medicine,2007,25(2):26-28.
7.高燕,陈航,袁爱军,等.实验性肾间质纤维化大鼠肾小管上皮细胞凋亡的观察[J].医学研究与教育,2009;26(4):11-13.
8.刘玉宁.肾间质纤维化的中医病机和治法探讨.新中医,2006,38(11):1-3.
9.许庆友,潘莉,王月华,等.红花对肾间质纤维化实验大鼠肾小管上皮细胞表型转化的抑制作用[J].中国老年学杂志,2009;29(11):1344-1346.
10.黄娟陈文莉朱虹.大黄酸对输尿管梗阻大鼠肾组织纤维化的保护机制[J].中国药师,2009;12(11):1529-1531.
11.林琼真,于洁,邓英辉,等.丹参注射液对大鼠梗阻性肾间质纤维化的保护作用[J].中国中西医结合肾病杂志,2003;4(2):71-73.
12.谢席胜,冯胜刚,左川,等.三七总皂甙对单侧输尿管梗阻后大鼠肾间质纤维化的作用及机制研究[J].西部医学,2010;22(2):210-214.
13.左川,谢席胜,邱红渝,等.黄芪对UUO大鼠肾间质纤维化拮抗作用[J].现代预防医学,2008;35(12):2298-2300.
14.谢红东,杨珂,穆焕德,等.黄芩提取物对大鼠肾间质纤维化的作用及其抗氧化机制[J].中国中西医结合肾病杂志,2009;10(3):240-242.
15.程虹,宋恩峰,杜仲对UUO模型大鼠肾纤维化TGF-β1/Smad信号通路的影响[J].中国中西医结合肾病杂志,2009;10(6):502-504.
16.项琼,宋恩峰,贾汝汉,等,泽兰对单侧输尿管梗阻大鼠肾间质纤维化的影响[J].中国中西医结合肾病杂志,2009;10(3):197-200.
17.李相军,王丹,石艳,等,银杏叶提取物对体外培养大鼠肾成纤维细胞作用的实验研究[J].中国实验诊断学,2010;14(1):45-47.
18.程晓霞,王军,周大为.人工虫草提取物对大鼠单侧输尿管梗阻致肾小管间质损伤的保护作用[J].中国中西医结合肾病杂志,2004,5(8):440-442.
19.李小波,李均,师丽晶.桃仁对单侧输尿管梗阻大鼠肾组织NF-κB、 TNF-β1表达的影响.中国中医基础医学杂志,2006,12(7):526-527.
20.李均,李小波.温阳活血方对UUO大鼠肾组织TGF-β1表达的影响.中国中西医结合肾病杂志,2007,8(3):142--144.
21.孟立强,屈磊,李晓玫.黄芪当归合剂对肾间质纤维化的多靶点抑制作用[J].中国药理学通报,2006,22(3):296.
22.张聪,谌贻璞,杨彦芳,等.益肾软坚散对慢性马兜铃酸肾病大鼠模型肾间质纤维化的保护作用[J].中国中西医结合杂志,2005;25(8):714-718.
23.董华玲,马华,中药芪红合剂对肾间质纤维化模型大鼠肾组织中CTGF表达的影响[J].中外医药,2009;(4):10-12.
24.杨琳,刘丽,景朋,等.益气活血中药对肾间质纤维化大鼠肾组织中Ⅰ、Ⅲ型胶原,MMP-1和TIMP-1表达的影响[J].北京中医药,2009;28(10):816-818.
25.陆敏,周娟,王飞,等,血府逐瘀胶囊对单侧输尿管梗阻大鼠SnoN和Ski表达的影响[J].上海中医药大学学报,2008;22(6):35-38.
26.余亚敏,何泽云,陈北阳,等,六味地黄汤对大鼠单侧输尿管结扎后肾小管间质ColⅣ及TIMP-1表达的影响[J].湖南中医学院学报,2006,26(4):22-24.
27.彭亚军,张继波,何泽云,等,六味地黄汤对单侧输尿管结扎大鼠肾间质MCP—1及TGF-β1表达的影响[J].中国中西医结合肾病杂志,2009;10(7):587-590.
28.刘海军,于俊生,和络泄浊方防治单侧输尿管梗阻后大鼠肾间质纤维化的研究[J].山东中医杂志,2008;27(11):768-771.
29.谷丽丽,张雪梅,田莉瑛,等.中药超微粉碎技术的应用及进展.生命科学仪器,2008;6(8):49-52.
30.孙强,何应.当归超微粉的药剂学研究[J].中国药房,2007,18(15):1141-1143.
31.蔡光先,赵迪加,张水寒,等.中药微粉粒度的评价初探[J].中成药,2007.29(5):719-722.
32.刘永,付廷明,郭立玮,等.紫河车超细粉体的表征技术研究[J].中华中医药学刊,2007,25(4):833-834.
33.黎华明.中药超微饮片与汤剂治疗老年性皮肤瘙痒症75例疗效对比观察.中医药导报,2005;11(10):31-33.
34.张若君.中西医结合治疗慢性肺心病心力衰竭30例疗效观察.陕西中医学院学报,2009;10(1):32-33.
35.屈波,蔡光先,刘柏炎,等.超微六味地黄汤对孕期被动吸烟胎鼠脑Bax、 Bcl-2和Casepase-3的影响.实用预防医学,2008;15(6):1679-1682.